Publication: 398

Publication: 398

A front-line window of opportunity phase II study of sorafenib in patients with advanced non-small cell lung cancer.

URL

Google Scholar

Citation:: J Clin Oncol vol 25 (18s) 396s abstr 7547

Year:: 2007
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 270

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: A. A. Adjei J. R. Molina S. L. Hillman R. F. Luyun N. F. Reuter K. M. Rowland Jr J. R. Jett S. J. Mandrekar S. E. Schild

Networks:

Study: NCCTG-N0326
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: